Search Results
Found 1 results
510(k) Data Aggregation
(403 days)
TASMIN R
When used as a vertebral body replacement, the TASMIN® R devices are indicated for use to replace a vertebral body that has been resected or excised due to tumor or traumaffracture. The device is intended for use as a vertebral body replacement in the thoracolumbar spine (from T1 to L5) and is intended for use with supplemental internal fixation.
When used as an intervertebral fusion device, the TASMIN® R devices are intended for use at one level in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is to be used in patients who have had six months of non-operative treatment. The devices are intended for use with a supplemental internal fixation system and with autograft to facilitate fusion.
The basic shape of the TASMIN® R devices is a hollow structural frame having a rounded, tapered leading face. The upper and lower aspects of the implant are open with peaked teeth that assist in anchoring and seating the implant between the vertebral bodies. There are lateral fenestrations for bony in-growth. The device is available in a variety of sizes and angulations thereby enabling the surgeon to choose the size best suited to the individual pathology and anatomical condition.
The TASMIN® R device is a spinal intervertebral body fixation orthosis and intervertebral body fusion device.
Here's an analysis of the acceptance criteria and the study that proves the device meets them:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria (from recognized standards) | Reported Device Performance (TASMIN® R) |
---|---|
Mechanical performance, specifically static and dynamic compression, torsion, and compression shear properties, as per ASTM F2077. | Device performance demonstrated substantial equivalence to predicate devices. |
Subsidence properties, as per ASTM F2267. | Device performance demonstrated substantial equivalence to predicate devices. |
Material properties (PEEK-OPTIMA® LT1, Invibio® an ASTM F2026; Tantalum an ASTM F560) | TASMIN® R is manufactured from PEEK-OPTIMA® LT1 as described by ASTM F2026. Integral marker pins are manufactured from tantalum as described by ASTM F560. |
Basic design (hollow structural frame) | TASMIN® R has a hollow structural frame with a rounded, tapered leading face. Upper and lower aspects are open with peaked teeth. Lateral fenestrations are present. |
Sizes (widths, lengths, and heights) | Sizes are within the range(s) offered by predicate devices. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: The documentation refers to "worst case TETRIS™ and TASMIN® R devices" for finite element analysis and "worst case TASMIN® R devices" for physical testing. It does not specify the exact number of devices or scenarios considered. It is implied that representative "worst-case" configurations were selected for the evaluation.
- Data Provenance: The studies are described as "Finite element analysis simulations" and "Static and dynamic compression testing." This indicates the data was generated from engineering analyses and laboratory bench testing performed by the sponsor, SIGNUS Medizintechnik GmbH. The country of origin of the data is not explicitly stated, but the sponsor is based in Germany. The data is prospective in the sense that it was generated specifically for the premarket submission.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not applicable as the studies performed were bench testing and finite element analysis, not clinical studies requiring expert consensus on patient data. The "ground truth" for these types of studies is established by adherence to recognized ASTM standards and engineering principles.
4. Adjudication Method for the Test Set
This information is not applicable for bench testing and finite element analysis. Adjudication methods like 2+1 or 3+1 are typically used in clinical studies for interpretation of imaging or clinical outcomes.
5. If a Multi-Reader, Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
An MRMC comparative effectiveness study was not conducted. The device is a medical implant, not an AI-assisted diagnostic or therapeutic tool.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done
This information is not applicable. The device is a physical implant, not an algorithm.
7. The Type of Ground Truth Used
The ground truth used for these studies was derived from:
- Recognized Industry Standards: ASTM F2077 (for compression, torsion, compression-shear) and ASTM F2267 (for subsidence properties). These standards define the methodology and expected performance for intervertebral body fusion devices.
- Engineering Principles: Finite element analysis relies on established biomechanical and engineering principles to simulate mechanical behavior.
- Material Specifications: ASTM F2026 for PEEK-OPTIMA® LT1 and ASTM F560 for Tantalum, defining the accepted properties of the materials.
8. The Sample Size for the Training Set
This information is not applicable. The studies performed were bench testing and simulations, not machine learning studies that require a training set.
9. How the Ground Truth for the Training Set was Established
This information is not applicable as there was no training set for a machine learning algorithm. The "ground truth" for the device's performance was established by adherence to ASTM standards and engineering principles as described in point 7.
Ask a specific question about this device
Page 1 of 1